His primary areas of investigation include Internal medicine, Diabetes mellitus, Diabetic nephropathy, Endocrinology and Albuminuria. His Internal medicine research includes themes of Gastroenterology and Nephropathy. Peter Rossing has researched Diabetes mellitus in several fields, including Risk factor, Kidney disease and Cardiology.
His biological study deals with issues like Diabetic retinopathy, which deal with fields such as Pediatrics and Case-control study. In his study, which falls under the umbrella issue of Endocrinology, Clinical trial and Good clinical practice is strongly linked to Randomized controlled trial. The Albuminuria study which covers Urology that intersects with Spironolactone and Cohort.
Internal medicine, Diabetes mellitus, Albuminuria, Endocrinology and Type 2 diabetes are his primary areas of study. His research in Internal medicine intersects with topics in Type 1 diabetes and Cardiology. His Diabetes mellitus research is multidisciplinary, incorporating elements of Surgery, Kidney disease, Gastroenterology, Blood pressure and Hazard ratio.
His Albuminuria research incorporates themes from Randomized controlled trial, Aliskiren and Confidence interval. The Type 2 diabetes study combines topics in areas such as Placebo, Disease, Prospective cohort study and Type 2 Diabetes Mellitus. His research investigates the connection with Diabetic nephropathy and areas like Urinary system which intersect with concerns in Biomarker.
Peter Rossing mainly investigates Internal medicine, Diabetes mellitus, Type 2 diabetes, Kidney disease and Renal function. His Internal medicine study integrates concerns from other disciplines, such as Type 1 diabetes and Cardiology. His Diabetes mellitus study improves the overall literature in Endocrinology.
His Type 2 diabetes study combines topics in areas such as Creatinine, Microalbuminuria and Cohort. The study incorporates disciplines such as Kidney, Mineralocorticoid receptor, Dapagliflozin and Intensive care medicine in addition to Kidney disease. The concepts of his Renal function study are interwoven with issues in Placebo, Blood pressure, Atrial fibrillation and Urology.
His primary scientific interests are in Kidney disease, Diabetes mellitus, Internal medicine, Type 2 diabetes and Renal function. His Kidney disease research integrates issues from Guideline and Disease. His primary area of study in Diabetes mellitus is in the field of Type 1 diabetes.
His study focuses on the intersection of Internal medicine and fields such as Dapagliflozin with connections in the field of Diabetic nephropathy. His Type 2 diabetes research incorporates elements of Adipose tissue, Albuminuria, Mineralocorticoid receptor and Type 2 Diabetes Mellitus. His Renal function study is related to the wider topic of Endocrinology.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Management of Hyperglycemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
Melanie J. Davies;David A. D’Alessio;Judith Fradkin;Walter N. Kernan.
Diabetes Care (2018)
Management of hyperglycaemia in type 2 diabetes, 2018. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
Melanie J. Davies;Melanie J. Davies;David A. D’Alessio;Judith Fradkin;Walter N. Kernan.
2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASDThe Task Force for diabetes, pre-diabetes, and cardiovascular diseases of the European Society of Cardiology (ESC) and the European Association for the Study of Diabetes (EASD)
Francesco Cosentino;Peter J Grant;Victor Aboyans;Clifford J Bailey.
European Heart Journal (2020)
Associations of kidney disease measures with mortality and end-stage renal disease in individuals with and without diabetes: a meta-analysis
Caroline S. Fox;Kunihiro Matsushita;Mark Woodward;Mark Woodward;Henk J.G. Bilo.
The Lancet (2012)
Lower estimated glomerular filtration rate and higher albuminuria are associated with mortality and end-stage renal disease. A collaborative meta-analysis of kidney disease population cohorts
Brad C. Astor;Kunihiro Matsushita;Ron T. Gansevoort;Marije Van Der Velde.
Kidney International (2011)
Predictors of mortality in insulin dependent diabetes: 10 year observational follow up study
Peter Rossing;Philip Hougaard;Knut Borch-Johnsen;Hans Henrik Parving.
Prevalence of micro- and macroalbuminuria, arterial hypertension, retinopathy and large vessel disease in European type 2 (non-insulin-dependent) diabetic patients.
M. A. Gall;P. Rossing;P. Skøtt;P. Damsbo.
Predictors for the development of microalbuminuria and macroalbuminuria in patients with type 1 diabetes: inception cohort study.
Peter Hovind;Lise Tarnow;Peter Rossing;Berit Ruud Jensen.
Progression of nephropathy in type 2 diabetic patients.
Kasper Rossing;Per K. Christensen;Per K. Christensen;Peter Hovind;Peter Hovind;Lise Tarnow;Lise Tarnow.
Kidney International (2004)
Progression of diabetic nephropathy
Peter Hovind;Peter Rossing;Lise Tarnow;Ulla M. Smidt.
Kidney International (2001)
Profile was last updated on December 6th, 2021.
Research.com Ranking is based on data retrieved from the Microsoft Academic Graph (MAG).
The ranking h-index is inferred from publications deemed to belong to the considered discipline.
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: